Medpace Holdings, Inc. (MEDP) は上場企業です ヘルスケア セクターの Medical - Diagnostics & Research 業界で事業展開. 本社所在地は Cincinnati, OH, アメリカ. 現CEOは August James Troendle.
MEDP を有する IPO日 2016-08-11, 5,900 名の正社員, に上場 NASDAQ Global Select, 時価総額 $14.85B.
Medpace Holdings, Inc. is a clinical research organization that provides comprehensive drug and medical device development services to pharmaceutical, biotechnology, and medical device companies across North America, Europe, and Asia. The company supports the entire clinical development lifecycle from Phase I through Phase IV trials, offering specialized services including clinical monitoring, regulatory affairs, data management, pharmacovigilance, and post-marketing support across multiple therapeutic areas. Medpace also provides specialized laboratory services including bio-analytical testing, clinical human pharmacology, imaging services, and electrocardiography support. Founded in 1992 and headquartered in Cincinnati, Ohio, the company serves as a trusted partner in advancing new drug and device candidates toward regulatory approval.
